Patient access to experimental drugs and AIDS clinical trial designs: ethical issues.
Schüklenk
U
U
Monash University Centre for Human Bioethics, Australia.
Hogan
C
C
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D002985:Clinical Protocols / Q000592:standards; D035061:Control Groups; D015507:Drugs, Investigational / Q000627:therapeutic use*; D028744:Ethics Committees, Research; D004992:Ethics, Medical; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006297:Health Services Accessibility; D006801:Humans; D007880:Legislation, Drug; D008297:Male; D028681:Moral Obligations; D010332:Paternal Behavior; D026706:Paternalism; D010349:Patient Compliance; D018579:Patient Selection; D026684:Personal Autonomy; D009272:Persons; D010919:Placebos; D011237:Predictive Value of Tests; D011634:Public Health; D016032:Randomized Controlled Trials as Topic / Q000592:standards*; D012107:Research Design / Q000592:standards; D035842:Research Subjects; D036302:Therapeutic Human Experimentation; D014481:United States; D035862:Vulnerable Populations
D015507:Drugs, Investigational; D010919:Placebos